Hepatits C Virus (HCV) is among the leading causes of liver cirrhosis, hepatocellular carcinoma, and liver transplantation. Over the past few years major breakthroughs have been made in treatment of HCV with the advent of all-oral direct acting antiviral (DAA) regiments. Intermountain is partnering with industry sponsors to conduct clinical trials that evaluate the efficacy and safety of these new therapeutic regimens. Intermountain is also following patients who have achieved a sustained viral response (SVR) to HCV in long-term registry studies in order to assess the durability of SVR.
Get Care Now
Get care for low-level urgent conditions through a video chat with a provider, 24/7, on your computer or mobile device.Learn More.
View wait times and save your place in line at an Intermountain InstaCare location near you.
If this is an emergency please go to the nearest emergency room or call 911.
Intermountain Healthcare is a Utah-based, not-for-profit system of 23 hospitals, a Medical Group with more than 1,600 physicians and advanced practice clinicians at about 180 clinics, a health plans division called SelectHealth, and other health services. Helping people live the healthiest lives possible, Intermountain is widely recognized as a leader in clinical quality improvement and efficient healthcare delivery.
Still not finding what you are looking for?
Copyright ©2019, Intermountain Healthcare, All rights reserved.